To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.

Summary

Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 September 2007

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 September 2007

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 25 September 2007

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.